H
Harlan M. Krumholz
Researcher at Yale University
Publications - 1966
Citations - 177853
Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.
Papers
More filters
Journal ArticleDOI
Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention
Jing Li,Kumar Dharmarajan,Kumar Dharmarajan,Xi Li,Zhenqiu Lin,Sharon-Lise T. Normand,Harlan M. Krumholz,Lixin Jiang +7 more
TL;DR: Examination of patient characteristics, diagnostic testing patterns, procedural treatments and in-hospital outcomes, including death, complications of treatment and costs of hospitalisation in China will help translate research into improved care for patients.
Journal ArticleDOI
Emphasizing the burden of proof: The American College of Cardiology 2008 Expert Panel Comments on the ENHANCE Trial.
TL;DR: It is not possible to know at this point whether ezetimibe was beneficial, harmful, or without a clinically important effect, given the current body of evidence, and the statement emphasized that the clinical effect of a drug cannot be inferred based solely on its effect on a biomarker.
Journal ArticleDOI
Internal medicine residents’ clinical and didactic experiences after work hour regulation
TL;DR: In response to work hour regulation, many internal medicine programs redistributed rather than reduced residents’ inpatient clinical experience, and many reduced third-year elective time.
Journal ArticleDOI
Keeping the Patient in View Defining the Appropriateness of Percutaneous Coronary Interventions
TL;DR: Randomized trials of PCI versus medical therapy in patients with chronic stable angina suggest that routine revascularization has no effect on the risk of death or myocardial infarction and that its benefits are restricted to reducing angina and improving exercise tolerance.
Posted Content
A Scalable Data Science Platform for Healthcare and Precision Medicine Research
Jacob McPadden,Thomas J S Durant,Dustin R. Bunch,Andreas Coppi,Nathan D. Price,Kris Rodgerson,Charles J Torre,William Byron,H. Patrick Young,Allen L. Hsiao,Harlan M. Krumholz,Wade L. Schulz +11 more
TL;DR: The implementation and use of integrated data science platforms offer organizations the opportunity to combine traditional data sets, including data from the electronic health record, with emerging big data sources, such as continuous patient monitoring and real-time laboratory results.